Search for Clinical Trial Results

Sponsored By

Oligodendroglioma - 26 Studies Found

Status Study
Completed Study Name: Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
Condition:
  • Anaplastic Astrocytomas
  • Anaplastic Oligodendrogliomas
  • Date: 2012-08-02
    Interventions: Drug: Etirinotecan pegol Other Name: NKTR-102
Not yet recruiting Study Name: Phase 1 Two Part Dose Escalation Trial of RRx-001 + Radiation + Temozolomide and RRx-001 + Temozolomide Post-RT In Newly Diagnosed Glioblastoma and Anaplastic Gliomas
Condition:
  • Glioblastoma
  • Oligodendroglioma
  • Anapl
    Date: 2016-08-11
    Interventions:
    • Drug: RRx-001 dose escalation with TMZ + RT

Terminated Study Name: Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.
Condition:
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Date: 2008-03-20
    Interventions: Other: MRS Spectroscopy Magnetic Resonance Spectroscopy us
Recruiting Study Name: Carboplatin in Treating Patients With Recurrent High-Grade Gliomas
Condition:
  • Adult Anaplastic Astrocytoma
  • Adult Anaplastic Oligodendroglioma
    Date: 2012-07-17
    Interventions:
    • Drug: carboplatin Carboplatin

Completed Study Name: A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
Condition:
  • Glioblastoma
  • Gliosarcoma
  • Anaplastic Astrocytoma
  • Date: 2008-08-13
    Interventions: Drug: Nanoliposomal CPT-11 Depending on UGT1A1 genotyping status, patients are either given a starting d
Completed Study Name: A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas
Condition: Glioma
Date: 2007-09-07
Interventions:
  • Drug: RTA 744 Aqueous solution
Suspended Study Name: Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
Condition:
  • Anaplastic Astrocytoma
  • Anaplastic Oligodendroglioma
  • Date: 2006-10-18
    Interventions:
    • Biological: Carcinoembryonic Antigen-Expressing Measles Virus

Terminated Study Name: Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
Condition:
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Date: 2003-06-06
    Interventions: Drug: Talampanel 10mg, 25 mg, 35 mg, 50 mg, 75mg TID for 3 weeks
Completed Study Name: Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours
Condition: Oligodendrogliomas
Date: 2005-09-13
Completed Study Name: Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma
Condition: Brain and Central Nervous System Tumors
Date: 1999-11-01
Interventions:
  • Drug: antineoplaston A10
  • Drug: antineoplas
<<< Previous | Next >>>